Bank of Montreal
CRL icon

Bank of Montreal’s Charles River Laboratories CRL Stock Holding History

Bank of Montreal’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,000
Closed -$997K – 3790
2025
Q4 		$997K Buy
+5,000
New +$907K ﹤0.01% 1978
2020
Q2 		– Sell
-10,000
Closed -$1.22M – 4651
2020
Q1 		$1.22M Buy
+10,000
New +$1.5M ﹤0.01% 1631

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of Montreal's CRL Position: Q1 2026 in Review

Bank of Montreal increased its Charles River Laboratories (CRL) stake by 15% in Q1 2026, buying an estimated $10.7M and bringing the position to 445,869 shares worth $76.9M. The position accounts for 0.03% of the portfolio, ranked #422.

Bank of Montreal first reported a position in CRL in Q2 2013 and has held it in 52 quarters since. The position peaked at $77.4M in Q4 2025. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Bank of Montreal held 445,869 shares of Charles River Laboratories worth $76.9M as of Q1 2026.
  • Bank of Montreal bought 57,952 Charles River Laboratories shares in Q1 2026, an estimated $10.7M.
  • Charles River Laboratories made up 0.03% of Bank of Montreal's portfolio in Q1 2026, its #422 holding.
  • Bank of Montreal first reported a position in Charles River Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Bank of Montreal's Charles River Laboratories position peaked at $77.4M in Q4 2025.
  • 558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.